This post hoc analysis of the AREDS and AREDS2 trials investigates potential associations between reticular pseudodrusen and cardiovascular disease events or related mortality.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Spectrum of Aldosteronism and Cardiovascular Outcomes | 0 | 6.27 | 01-04-2026 |
| 2 | Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion | 0 | 11.23 | 01-12-2023 |
| 3 | Left Ventricular Dimension and Mortality in Patients With Heart Failure | 0 | 3.96 | 05-08-2026 |
| 4 | Раскрыт повышающий риск смерти от болезней сердца фактор | -5 | 7 | 02-07-2026 |
| 5 | Reassessing Treatment Outcomes Following Immune-Related Adverse Events—Reply | 0 | 10.34 | 01-07-2026 |
| 6 | Metformin Use and Age-Related Macular Degeneration in Patients With Diabetes | 0 | 9.02 | 01-07-2026 |
| 7 | Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease | 0 | 8.74 | 28-07-2026 |
| 8 | Cardiac Risk After Heart-Sparing Breast Radiotherapy | 0 | 5 | 02-07-2026 |
| 9 | Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction | 0 | 5.21 | 08-07-2026 |